[In the Media] “Japan must face up to growing danger of drug-resistant germs” (NIKKEI ASIA, October 12, 2022)
date : 10/17/2022
Tags: AMR
On October 12, 2022, Nikkei Asia published an editorial by Mr. Ryoji Noritake, CEO and Board Member of Health and Global Policy Institute (HGPI) and Mr. Michael W. Hodin, CEO of the Global Coalition on Aging (GCOA), that was written in collaboration between HGPI and GCOA – “Japan must face up to growing danger of drug-resistant germs.”
The editorial addresses the situation of Antimicrobial Resistance (AMR) and related counter-measures in Japan, including four critical action areas to amend the Japan’s 2016-2020 National Action Plan on AMR. They include an establishment of pull-incentives, fostering greater collaboration among stakeholders through organizations like AMR Alliance Japan, a promotion of fundamental infectious disease control by vaccines and related measures, and strengthening testing and surveillance systems from the viewpoint of One Health.
For further information, please refer to the editorial
日本語
Top Research & Recommendations Posts
- [Announcement] HGPI Joins Alliance for Transformative Action on Climate and Health (April 22, 2024)
- [Announcement] A Significant Step Towards the Building a Green Healthcare System: Support for the Formal Expression of Interest by the Japanese Government Delegation to the ATACH at the Executive Board Meeting of the WHO (February 16, 2024)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Research Report] Survey of Japanese Physicians Regarding Climate Change and Health (December 3, 2023)
- [Research Report] 2019 Survey on Healthcare in Japan
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
- [Event Report] Planetary Health Expert Meeting Aiming for Sustainable Healthcare: Learning from the Impact of Environmental Pollution and Medical Waste During the Pandemic (February 16, 2024)
- [Publication Report] Developing and Expanding Cardiovascular Disease Control Plans in Each Prefecture – Challenges and Good Examples for Cardiovascular Disease Control (September 7, 2023)
- [Public Comment Submission] Opinions Regarding the Proposed “National Action Plan on Antimicrobial Resistance 2023-2027 (Draft)” (March 16, 2023)
- [Report and Recommendations] Discussion Points in Healthcare DX Project Expert Panel Meeting (April 2, 2024)
Featured Posts
-
2024-04-22
[Registration Open] (Hybrid Format) Intractable Disease Day Symposium: Future Measures for Intractable Diseases from the Perspectives of Patients and Citizens (May, 23 2024)
-
2024-04-23
[Registration Open] (Webinar) The 125th HGPI Seminar: Progress and Prospects for Domestic Measures on Health Problems Caused by Alcohol (May 24 , 2024)
-
2024-04-30
[Event Report] Non-partisan Diet Member Briefing – 30-minute Health Policy Update: “Community Development for Senior Health: From Establishing Evidence to Social Implementation” (April 23, 2024)
-
2024-05-02
[Event Report] The 123rd HGPI Seminar – The Current Situation and Future Prospects for Epilepsy in Japan and Around the World (March 6, 2024)
-
2024-05-09
[Registration Open] The Health Policy Academy the 13th Session